Medium materiality6/10
H.C. Wainwright Reiterates Buy Rating on Eupraxia Pharmaceuticals (EPRX)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy on EPRX; target $11; current price $9.10; price fell 11.59% since signal.
- Target $11; price $9.10; Buy reiterated by H.C. Wainwright.
Key facts
- 01
Target: $11
- 02
Posted price: $9.1
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Brandon Folkes
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.